机构地区:[1]华中科技大学同济医学院附属同济医院器官移植研究所,武汉430030
出 处:《中华器官移植杂志》2013年第9期550-553,共4页Chinese Journal of Organ Transplantation
基 金:国家自然科学基金(81072442)
摘 要:目的研究树突状细胞(DC)中Toll样受体(TLR)信号通路在小鼠皮肤移植排斥反应中的作用。方法体外诱导培养得到BALB/c小鼠骨髓源性的不成熟DC,加入TLR激动剂CpG刺激细胞成熟,实验组同时加入TLR通路关键分子MyD88的抑制剂ST2825,24h后用流式细胞仪检测IX2共刺激分子CD80和CD86的表达;用荧光染料CFSE标记的C57BL/6小鼠T淋巴细胞与BALB/c小鼠的DC在CpG刺激下行混合淋巴细胞培养,实验组同时加入ST2825,培养3d后用流式细胞仪检测T淋巴细胞的增殖情况。建立BALB/c小鼠次要组织相容性抗原HY错配皮肤移植模型,供鼠均为雄性小鼠,受鼠均为雌性小鼠,在此基础之上分为对照组(供受鼠均为野生型BALB/c小鼠)、MyD88组(供受鼠均为MyDS8基因敲除的BALB/c小鼠)、DC组(供受鼠均为MyD88基因敲除的BALB/c小鼠,移植后输注供鼠来源的DC)、实验组(供受鼠均为MyD88基因敲除的BALB/c小鼠,输注经ST2825预处理的供者来源DC)。观察各组移植皮片的存活时间。结果TLR通路抑制剂ST2825可以剂量依赖性地抑制CpG刺激引起的DC共刺激分子CDS0和CD86的高表达。经Cpg刺激的IX;可以诱导同种反应性T淋巴细胞的大量增殖,ST2825可以呈剂量依赖性地抑制此反应。对照组移植物的存活时间为(22.8±2.8)d;MyD88组移植物均未发生排斥反应(存活时间超过100d);DC组移植物存活时问为(9.7±2)d;实验组移植物亦未发生排斥反应(存活时间超过100d),较DC组显著延长(P〈0.05)。结论DC通过TLR信号通路在移植排斥反应中发挥关键作用,TLR信号通路抑制剂ST2825能够抑制DC的激活和生物学功能,其机理可能与ST2825抑制DC成熟,并间接抑制同种反应性T淋巴细胞的增殖有关。Objective To investigate the essential role of Toll-like receptor (TLR) signaling in dendritic cells in rejection responses of skin transplantation in mice. Method Immature wild type BALB/c bone marrow dentritic cells (BIVIDCs) were stimulated by a TLR agonist, CpG, in the presence of ST2825, an inhibitor of key molecule myeloid differentiation factor 88 (MyD88) in TLR signal transduction, or in the absence for 24 h in vitro. Co-stimulatory molecules CDS0 and CD86 were analyzed by flow cytometry. Wild-type C57BL/6 na ve T cells stained with CFSE, a fluorescent dye, were co-cultured with BALB/c DCs for 3 days in the presence or absence of ST2825. CD3±/CFSE± cells were analyzed by flow cytometry. Minor antige-mismatched (HY-mismatched) skin allograft model was employed in this study in which the donors were all males and the recipients were all females. The experimental groups were divided as follows-, the control group, the donors and the recipients were all wide type BALB/c mice; the MyD88 group, the donors and the recipients were all MyD88-konckout BALB/c mice; the DCs group, the donors and the recipients were all MyD88- knockout BALB/c mice and the recipients were transfused with donor-sourced DCs after transplantation; the experimental group, the donors and the recipients were all MyD88 knockout BALB/c mice and the recipients were transfused with dono〉sourced DCs pre-treated with ST2825 after transplantation. The survival time of skin allografts was observed. Result ST2825 could dose-dependently inhibit the high level expression of co-stimulatory molecules CD80 and CD86 induced with CpG. Similarly, and it could also dose-dependently inhibit the allo-reactive T cell proliferation upon the stimulation with DCs. The survival time of every group was as follows: the control group (22. 8 ± 2.8) days vs. the MyD88 group (〉100 days) vs. the DCs group (9. 7 ± 2) days vs. the experimental group (〉100 days, P〈0.05, vs. the DC group). Conclusion DCs may play an essential role
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...